Literature DB >> 17620846

Sedation for gastrointestinal endoscopy: the changing landscape.

John Trummel1.   

Abstract

PURPOSE OF REVIEW: Most patients require sedation for gastrointestinal endoscopy. Moderate sedation for these procedures has traditionally been provided by the endoscopist with benzodiazepine and/or a narcotic. As endoscopy has increased in numbers and complexity, however, more effective sedation and analgesia is frequently required. Controversy has ensued over safe and efficient sedation practice. This review seeks to delineate what has been learned about this topic in the recent literature. RECENT
FINDINGS: There has been an increase both in the number of endoscopic procedures performed and in the use of propofol for endoscopic sedation. Studies have focused on several basic issues: alternatives to anesthesiologist-supervised propofol, other sedation regimens, and complications related to sedation.
SUMMARY: Alternatives to anesthesiologist-supervised propofol include nurse-administered propofol sedation supervised by the endoscopist, and patient controlled sedation. While other sedative regimens continue to be examined, the use of propofol for gastrointestinal endoscopy will continue to increase. Structured nurse-administered propofol programs appear to be safe, but the occurrence of severe respiratory depression and the ability to rescue remain concerns. Further study into appropriate sedation training, patient selection, ability to rescue, complications and value of anesthesiologist-directed sedation is necessary.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17620846     DOI: 10.1097/ACO.0b013e32827ab467

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  8 in total

1.  Double balloon enteroscopy examinations in general anesthesia.

Authors:  Laszlo Zubek; Lena Szabo; Peter Laszlo Lakatos; Janos Papp; Janos Gal; Gabor Elo
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

2.  Patient satisfaction after endoscopic submucosal dissection under propofol-based sedation: a small premedication makes all the difference.

Authors:  Seokyung Shin; Chan Hyuk Park; Hyun Ju Kim; Sang Hun Park; Sang Kil Lee; Young Chul Yoo
Journal:  Surg Endosc       Date:  2016-10-14       Impact factor: 4.584

3.  Sedation for interventional gastrointestinal endoscopic procedures: are we overlooking the “pain”?

Authors:  Seokyung Shin; Sang Kil Lee; Kyung Tae Min; Hyun Ju Kim; Chan Hyuk Park; Young Chul Yoo
Journal:  Surg Endosc       Date:  2014-01       Impact factor: 4.584

4.  Practicability and patients' subjective experiences of low-dose spinal anaesthesia using hyperbaric bupivacaine for transanal surgery.

Authors:  Marc D Schmittner; Andrea Janke; Christel Weiss; Grietje C Beck; Dieter G Bussen
Journal:  Int J Colorectal Dis       Date:  2009-03-13       Impact factor: 2.571

5.  Safety of midazolam for sedation of HIV-positive patients undergoing colonoscopy.

Authors:  E S Backman; V A Triant; J M Ehrenfeld; Z Lu; P Arpino; E Losina; R T Gandhi
Journal:  HIV Med       Date:  2013-01-18       Impact factor: 3.180

6.  Ketamine, propofol and low dose remifentanil versus propofol and remifentanil for ERCP outside the operating room: is ketamine not only a "rescue drug"?

Authors:  Lea Paola Fabbri; Maria Nucera; Massimo Marsili; Mohamed Al Malyan; Chiara Becchi
Journal:  Med Sci Monit       Date:  2012-09

7.  Assessing the stability and safety of procedure during endoscopic submucosal dissection according to sedation methods: a randomized trial.

Authors:  Chan Hyuk Park; Seokyung Shin; Sang Kil Lee; Hyuk Lee; Yong Chan Lee; Jun Chul Park; Young Chul Yoo
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

8.  Conventional versus Analgesia-Oriented Combination Sedation on Recovery Profiles and Satisfaction after ERCP: A Randomized Trial.

Authors:  Seokyung Shin; Tak Geun Oh; Moon Jae Chung; Jeong Youp Park; Seung Woo Park; Jae Bok Chung; Si Young Song; Jooyoun Cho; Sang-Hun Park; Young Chul Yoo; Seungmin Bang
Journal:  PLoS One       Date:  2015-09-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.